GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
GoodRx Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.37+0.01 (+0.30%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 84.3
- Dividend yield
- –
Share price
−$0.46 (−12.01%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
GoodRx Holdings, Inc. saw revenue fall 1.8% to $785.23M over the twelve months to Jun 30, 2026. Operating income fell 15.6% to $74.94M, moving the operating margin from 11.1% to 9.5%. Free cash flow was $197.09M, up 4.0% from a year earlier.
Revenue
$785.23M
-1.8% vs. a year earlier
Operating income
$74.94M
-15.6% vs. a year earlier
Free cash flow
$197.09M
+4.0% vs. a year earlier
EPS, diluted
$0.04
-60.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.17B
- P/E ratio
- 84.3
- Price to sales
- 1.49
- Price to book
- 1.81
- Dividend yield
- –
- Free cash flow yield
- 16.80%
Fundamentals
- Revenue
- $785.23M
- Net income
- $16.25M
- EPS, diluted
- $0.04
- Free cash flow
- $197.09M
- Book value per share
- $1.86
- Diluted shares
- 348M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
$785.23M-1.8% YoY
Gross profit
$713.19M-4.8% YoY
Operating income
$74.94M-15.6% YoY
Net income
$16.25M-53.0% YoY
EPS, diluted
$0.04-60.0% YoY
Free cash flow
$197.09M+4.0% YoY
Reported periodTrailing twelve months